Category : Search result: Daiichi Sankyo

Enhertu Breakthrough in Early Breast Cancer Treatment

Groundbreaking research reveals Enhertu significantly reduces recurrence risk in HER2-positive early breast cancer patients, marking a potential turning point in oncology care.